EPHX2 and endothelial dysfunction: A growing body of evidence indicates that lower plasma levels of EETs, frequently due to increased soluble epoxide hydrolase (sEH) activity, are linked with conditions such as hypertension, coronary artery disease, and endothelial dysfunction [5,6].